Loading...

National Research Corporation

NRC•NASDAQ
Healthcare
Medical - Healthcare Information Services
$17.23
$-0.02(-0.12%)
U.S. Market opens in 40h 37m

National Research Corporation (NRC) Stock Overview

Explore National Research Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap391.9M
P/E Ratio32.07
EPS (TTM)$0.50
ROE0.59%
Fundamental Analysis

AI Price Forecasts

1 Month$13.95
3 Months$13.98
1 Year Target$13.27

NRC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of National Research Corporation (NRC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.31, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $13.27.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 32.07 and a market capitalization of 391.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.12%
5-Day Change
-4.01%
1-Month Change
-1.20%
3-Month Change
-18.22%
6-Month Change
47.77%
Year-to-Date (YTD) Change
-8.20%
1-Year Change
61.03%
3-Year Change
-61.32%
5-Year Change
-64.81%
All-Time (Max) Change
-13.85%

Contact Information

https://nrchealth.com
402 475 2525
1245 Q Street, Lincoln, NE, 68508

Company Facts

368 Employees
IPO DateMay 23, 2013
CountryUS
Actively Trading

Frequently Asked Questions